International Variation in Prostate Cancer Incidence and Mortality Rates, European Urology, vol.61, issue.6, p.22424666, 2012. ,
DOI : 10.1016/j.eururo.2012.02.054
Prostate cancer epidemiology, Frontiers in Bioscience, vol.11, issue.1, pp.1388-1413, 2006. ,
DOI : 10.2741/1891
Prostate cancer, The Lancet, vol.371, issue.9625, pp.1710-1721, 2008. ,
DOI : 10.1016/S0140-6736(08)60729-1
The role of steroid hormones in prostate carcinogenesis, J Natl Cancer Inst Monogr, vol.27, pp.39-66, 2000. ,
Estrogen and prostate cancer: An eclipsed truth in an androgen-dominated scenario, Journal of Cellular Biochemistry, vol.354, issue.255, pp.899-911, 2007. ,
DOI : 10.1042/bse0400011
Estrogen Metabolites, Conjugates, and DNA Adducts: Possible Biomarkers for Risk of Breast, Prostate, and Other Human Cancers, Adv Clin Chem, vol.38, pp.135-149, 2004. ,
DOI : 10.1016/S0065-2423(04)38005-4
Enhanced induction of prostatic dysplasia and carcinoma in Noble rat model by combination of neonatal estrogen exposure and hormonal treatments at adulthood, Int J Oncol, vol.27, pp.1685-1695, 2005. ,
Combination of Polymorphisms From Genes Related to Estrogen Metabolism and Risk of Prostate Cancers: The Hidden Face of Estrogens, Journal of Clinical Oncology, vol.25, issue.24, pp.3596-3602, 2007. ,
DOI : 10.1200/JCO.2007.11.0908
Genetic susceptibility to prostate cancer, BJU International, vol.12, issue.9, pp.1380-1385, 2005. ,
DOI : 10.1007/s004390051102
CYP17 Gene Polymorphisms: Prevalence and Associations with Hormone Levels and Related Factors. A HuGE Review, American Journal of Epidemiology, vol.160, issue.8, pp.729-740, 2004. ,
DOI : 10.1093/aje/kwh287
URL : https://academic.oup.com/aje/article-pdf/160/8/729/370883/kwh287.pdf
Variants in Estrogen Biosynthesis Genes, Sex Steroid Hormone Levels, and Endometrial Cancer: A HuGE Review, American Journal of Epidemiology, vol.38, issue.3, pp.235-245, 2007. ,
DOI : 10.1021/bi9821059
URL : https://academic.oup.com/aje/article-pdf/165/3/235/17337337/kwk015.pdf
Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity, Cancer Res, vol.60, pp.3440-3444, 2000. ,
Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the Enzyme, Biochemistry, vol.34, issue.13, pp.4202-4210, 1995. ,
DOI : 10.1021/bi00013a008
Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5? nuclease assay, Psychopharmacology, vol.299, issue.1-2, pp.178-184, 2004. ,
DOI : 10.1126/science.1078546
Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7, Toxicol Sci, vol.45, pp.52-57, 1998. ,
DOI : 10.1093/toxsci/45.1.52
URL : https://academic.oup.com/toxsci/article-pdf/45/1/52/4826038/45-1-52.pdf
The Genetic Basis of the Reduced Expression of Bilirubin UDP-Glucuronosyltransferase 1 in Gilbert's Syndrome, New England Journal of Medicine, vol.333, issue.18, pp.1171-1175, 1995. ,
DOI : 10.1056/NEJM199511023331802
, Available: http://www.insee.fr/ [accessed 29, INSEE. Institut National de la Statistique et des Etudes Economiques, 2016.
, Bulletin de Veille Sanitaire Antilles- Guyane n°8, La surveillance des cancers dans les Antilles et en Guyane, 2011.
The Risk of Prostate Cancer amongst Black Men in the United Kingdom: The PROCESS Cohort Study, European Urology, vol.53, issue.1, pp.99-105, 2008. ,
DOI : 10.1016/j.eururo.2007.02.047
, Cancer Facts & Figures for African Americans, 2007.
http://globocan.iarc.fr/ [accessed 28, 2012. ,
Chlordecone Exposure and Risk of Prostate Cancer, Journal of Clinical Oncology, vol.28, issue.21, pp.3457-3462, 2010. ,
DOI : 10.1200/JCO.2009.27.2153
URL : https://hal.archives-ouvertes.fr/inserm-00518099
Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men, New England Journal of Medicine, vol.335, issue.5, pp.304-310, 1996. ,
DOI : 10.1056/NEJM199608013350502
Introduction to stratified analysis, Modern Epidemiology. Lippincott-Raven, pp.253-279, 1998. ,
Gene Polymorphisms on the Survival of Patients With Metastatic Prostate Cancer, Journal of Clinical Oncology, vol.24, issue.13, pp.1982-1989, 2006. ,
DOI : 10.1200/JCO.2005.02.9439
dbSNP: the NCBI database of genetic variation, Nucleic Acids Research, vol.29, issue.1, pp.308-311, 2001. ,
DOI : 10.1093/nar/29.1.308
URL : https://academic.oup.com/nar/article-pdf/29/1/308/9905801/290308.pdf
Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2), Carcinogenesis, vol.20, issue.9, pp.1727-1731, 1999. ,
DOI : 10.1093/carcin/20.9.1727
Cyp17 promoter variant associated with prostate canceraggressiveness in African Americans, Cancer Epidemiol. Biomarkers Prev, vol.10, pp.943-947, 2001. ,
A polymorphism in the CYP17 gene and risk of prostate cancer, Cancer Epidemiol. Biomarkers Prev, vol.11, pp.243-247, 2002. ,
Association of prostate cancer risk and aggressiveness to androgen pathway genes:SRD5A2,CYP17, and theAR, The Prostate, vol.1, issue.1, pp.69-76, 2004. ,
DOI : 10.1038/nm0295-99
Genetic polymorphisms inCYP17,CYP3A4,CYP19A1,SRD5A2,IGF-1, andIGFBP-3 and prostate cancer risk in African-American men: The Flint Men's Health Study, The Prostate, vol.8, issue.3, pp.296-305, 2008. ,
DOI : 10.1038/ncpuro0091
URL : http://europepmc.org/articles/pmc2712831?pdf=render
Single and Multigenic Analysis of the Association between Variants in 12 Steroid Hormone Metabolism Genes and Risk of Prostate Cancer, Cancer Epidemiology Biomarkers & Prevention, vol.18, issue.6, pp.1869-1880, 2009. ,
DOI : 10.1158/1055-9965.EPI-09-0076
No association of the 5??? promoter region polymorphism of CYP17 gene with prostate cancer risk, Prostate Cancer and Prostatic Diseases, vol.91, issue.Suppl 1, pp.28-31, 2002. ,
DOI : 10.1111/j.1349-7006.2000.tb01029.x
CYP17 gene polymorphisms and prostate cancer risk: A meta-analysis based on 38 independent studies, The Prostate, vol.123, issue.114, pp.1167-1177, 2011. ,
DOI : 10.1007/s00439-007-0454-8
Review of studies on metabolic genes and cancer in populations of African descent, Genetics in Medicine, vol.160, issue.1, 2010. ,
DOI : 10.1093/aje/kwh294
and prostate cancer in men of African descent, The Prostate, vol.160, issue.4, pp.668-676, 2013. ,
DOI : 10.1093/aje/kwh294
No association between a tetranucleotide repeat polymorphism of CYP19 and prostate cancer, Cancer Epidemiol Biomarkers Prev, vol.13, pp.2280-2281, 2004. ,
Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population, Anticancer Res, vol.23, pp.4941-4946, 2003. ,
Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis, Molecular Biology Reports, vol.14, issue.1, pp.7465-7471, 2012. ,
DOI : 10.1158/1078-0432.CCR-04-2545
Val158Met Polymorphism and Prostate Cancer Risk: A Meta-Analysis, Genetic Testing and Molecular Biomarkers, vol.17, issue.1, pp.78-84, 2013. ,
DOI : 10.1089/gtmb.2012.0216
Lack of Association between COMT Val158Met Polymorphism and Prostate Cancer Susceptibility, Urologia Internationalis, vol.91, issue.2, pp.213-219, 2013. ,
DOI : 10.1159/000345633
The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis, Molecular Biology Reports, vol.14, issue.2, pp.1835-1841, 2013. ,
DOI : 10.1158/1055-9965.EPI-04-0479
Tea intake, COMT genotype, and breast cancer in Asian-American women, Cancer Res, vol.63, pp.7526-7529, 2003. ,
DOI : 10.1002/ijc.22387
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.22387/pdf
O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase, Drug Metab Dispos, vol.28, pp.1024-1030, 2000. ,
Genetic Association Between the COMT Genotype and Urinary Levels of Tea Polyphenols and Their Metabolites among Daily Green Tea Drinkers, Int J Mol Epidemiol Genet, vol.1, pp.114-123, 2010. ,
Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men, Cancer Epidemiology, vol.34, issue.3, pp.345-349, 2010. ,
DOI : 10.1016/j.canep.2010.02.009
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial, Carcinogenesis, vol.45, issue.10, pp.1500-1506, 2011. ,
DOI : 10.1016/j.canep.2010.02.009
No Adjustments Are Needed for Multiple Comparisons, Epidemiology, vol.1, issue.1, pp.43-46, 1990. ,
DOI : 10.1097/00001648-199001000-00010